Risk adapted approach: How to treat splenic marginal zone lymphoma in resource-poor settings? - The real-life experience of a Brazilian cancer treatment center (2020)
- Authors:
- USP affiliated authors: ROCHA, VANDERSON GERALDO - FM ; PEREIRA, JULIANA - FM
- Unidade: FM
- DOI: 10.1186/s12885-020-07204-6
- Subjects: ANÁLISE DE VARIÂNCIA; ANTINEOPLÁSICOS; PAÍSES DESENVOLVIDOS; LINFOMA; PROGNÓSTICO; ESTUDOS RETROSPECTIVOS; ESPLENECTOMIA
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Bmc cancer
- ISSN: 1471-2407
- Volume/Número/Paginação/Ano: v. 20, n. 1, article ID 717, 12p, 2020
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
LAGE, Luis Alberto de Padua Covas et al. Risk adapted approach: How to treat splenic marginal zone lymphoma in resource-poor settings? - The real-life experience of a Brazilian cancer treatment center. Bmc cancer, v. 20, n. 1, 2020Tradução . . Disponível em: https://doi.org/10.1186/s12885-020-07204-6. Acesso em: 19 set. 2024. -
APA
Lage, L. A. de P. C., Santos, F. F. C. dos, Levy, D., Moreira, F. R., Couto, S. C. F., Culler, H. F., et al. (2020). Risk adapted approach: How to treat splenic marginal zone lymphoma in resource-poor settings? - The real-life experience of a Brazilian cancer treatment center. Bmc cancer, 20( 1). doi:10.1186/s12885-020-07204-6 -
NLM
Lage LA de PC, Santos FFC dos, Levy D, Moreira FR, Couto SCF, Culler HF, Costa R de O, Rocha VG, Pereira J. Risk adapted approach: How to treat splenic marginal zone lymphoma in resource-poor settings? - The real-life experience of a Brazilian cancer treatment center [Internet]. Bmc cancer. 2020 ; 20( 1):[citado 2024 set. 19 ] Available from: https://doi.org/10.1186/s12885-020-07204-6 -
Vancouver
Lage LA de PC, Santos FFC dos, Levy D, Moreira FR, Couto SCF, Culler HF, Costa R de O, Rocha VG, Pereira J. Risk adapted approach: How to treat splenic marginal zone lymphoma in resource-poor settings? - The real-life experience of a Brazilian cancer treatment center [Internet]. Bmc cancer. 2020 ; 20( 1):[citado 2024 set. 19 ] Available from: https://doi.org/10.1186/s12885-020-07204-6 - Acquired hemophagocytic lymphohistiocytosis as initial manifestation of multiple myeloma A case report and literature review
- Clinical, laboratory and genetic features of Erdheim-Chester disease patients: analysis of a retrospective cohort of two reference centers in Latin America
- Less intensive regimens may still be suitable for the initial treatment of primary mediastinal B-Cell lymphoma in resource-limited settings
- Absolute monocyte count is a predictor of overall survival and progression-free survival in nodal peripheral T cell lymphoma
- Outcomes of HIV-associated Burkitt Lymphoma in Brazil: High treatment toxicity and refractoriness rates - A multicenter cohort study
- Diagnostic and prognostic implications of tumor expression of the GATA-3 gene in nodal peripheral T-cell lymphoma (nPTCL): retrospective data from a Latin American cohort
- CD4+ lymphocytes in asymptomatic HTLV-1 carriers present cell cycle arrest in GO/G1 phase
- Expression of CysLTR1 and 2 in Maturating Lymphocytes of Hyperplasic Tonsils Compared to Peripheral Cells in Children
- Macrophage migration inhibitory factor and chemokine RANTES in young pediatric patients with congenital cardiac communications: relation to hemodynamic parameters and the presence of Down syndrome
- Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma
Informações sobre o DOI: 10.1186/s12885-020-07204-6 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
